Family Office Of America (FOFA) Liabilities and Shareholders Equity (2021 - 2026)
Family Office Of America (FOFA) posted Liabilities and Shareholders Equity of $2.3 million for Q1 2026, up 46.53% sequentially from $1.5 million in Q4 2025, and up 296.35% YoY from $570468.0 in Q1 2025.
Family Office Of America (FOFA) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Family Office Of America has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $2.3 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 296.35% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 644.74% YoY) and the FY2025 annual result came in at $1.5 million, up 7397.41% from the prior year.
- Liabilities and Shareholders Equity grew to $2.3 million in Q1 2026 per FOFA's latest filing, from $1.5 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $2.3 million in Q1 2026 and troughed at $2431.0 in Q4 2023.
- A 5-year average of $476445.1 and a median of $239812.0 in 2022 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity slumped 99.18% in 2023, then jumped 7397.41% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $295461.0 in 2022, then plunged by 99.18% to $2431.0 in 2023, then jumped by 746.61% to $20581.0 in 2024, then surged by 7397.41% to $1.5 million in 2025, then jumped by 46.53% to $2.3 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.3 million, $1.5 million, and $829347.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | 2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 829,347.00 |
| Jun 30, 2025 | 588,771.00 |
| Mar 31, 2025 | 570,468.00 |
| Dec 31, 2024 | 20,581.00 |
| Sep 30, 2024 | 46,704.00 |
| Jun 30, 2024 | 63,456.00 |
| Mar 31, 2024 | 90,571.00 |
| Dec 31, 2023 | 2,431.00 |
| Sep 30, 2023 | 121,938.00 |
| Jun 30, 2023 | 149,510.00 |
| Mar 31, 2023 | 184,163.00 |
| Dec 31, 2022 | 295,461.00 |
| Sep 30, 2022 | 453,199.00 |
| Jun 30, 2022 | 402,437.00 |
| Dec 31, 2021 | 800,063.00 |